Alert: Major Price Decline (3/18/25)-Catalyst Biosciences Inc (NASDAQ: GYRE).

out_logo_500#72885.jpg

Catalyst Biosciences Inc (NASDAQ: GYRE) stock closed at $8.57 on 3/18/25 after a major decline of -30.2%. Moreover, trading volume in this decline was exceptionally high at 812% of normal. The stock has declined -17.0% during the last week and has been weak relative to the market over the last nine months.

out_mm#72885.jpg

Current PriceTarget Research Rating

Catalyst Biosciences is currently unrated.

Rating Review

The stock is currently unrated.

Be the first to comment

Leave a Reply

Your email address will not be published.


*